Last reviewed · How we verify

NCT07100821

Thoracic Fluid Content as an Outcome Predictor in Intensive Care Unit

Completed Last updated 13 August 2025
What this trial tests

trial testing Hemodynamic parameters was measured by using electric cardiometry (ICON) in Thoracic Diseases in 130 participants. Completed in 1 December 2024.

Timeline
1 December 2023
Primary endpoint
1 June 2024
1 December 2024

Quick facts

Lead sponsorMansoura University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment130
Start date1 December 2023
Primary completion1 June 2024
Estimated completion1 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University Hospital

Who can join

18 and older, any sex, with Thoracic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hemodynamic monitoring is measuring and monitoring the factors that influence the force and flow of the blood. It is an important aspect of patients care in operating rooms and critical care units. It aims to guide medical management so as to prevent or treat organ failure and improve the outcomes of patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prognostic Value of Electrical Cardiometry–Derived Thoracic Fluid Content in Respiratory Intensive Care Unit Patients: A Prospective Observational Study
    Mohamed MA, Elshafey MM, Elsaid AR, Foad AGA, et al · · 2025 · DOI 10.21203/rs.3.rs-7895080/v1

Verify or expand the search:

Other recruiting trials for Thoracic Diseases

Currently open trials in the same condition.

Other Mansoura University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07100821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing